CD8A and primary cutaneous T-cell non-Hodgkin lymphoma: This represents a major limitation, as not being able to distinguish between different phenotypes of T cells or the presence of reactive CD8+ clones in skin or blood can hinder diagnosis and management of CTCL patients.